Development of a self-report scale of spasticity.

about

Development of a self-report scale of spasticity.

Item

http://www.wikidata.org/entity/Q43992593

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Development of a self-report scale of spasticity.

@en

Development of a self-report scale of spasticity.

@en-gb

Development of a self-report scale of spasticity.

@nl

type

Item

label

Development of a self-report scale of spasticity.

@en

Development of a self-report scale of spasticity.

@en-gb

Development of a self-report scale of spasticity.

@nl

prefLabel

Development of a self-report scale of spasticity.

@en

Development of a self-report scale of spasticity.

@en-gb

Development of a self-report scale of spasticity.

@nl

P1476

Development of a self-report scale of spasticity.

@en

P2093

Mike Horton

http://www.w3.org/2001/XMLSchema#string

Ruth M Kent

http://www.w3.org/2001/XMLSchema#string

Steve Barker

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines to statistical evaluation of data from rating scales and questionnaires.

Measuring handicap: the London Handicap Scale, a new outcome measure for chronic disease.

Prevalence of self reported stroke in a population in northern England.

Handicap one year after a stroke: validity of a new scale

Confirmatory factor analysis of the validity of the SF-12 for persons with and without a history of stroke

Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).

The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper?

Spasticity after stroke: an overview of prevalence, test instruments, and treatments.

Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial.

Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis.

P304

485-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1310/TSR2006-485

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alan Tennant

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24273295

http://www.w3.org/2001/XMLSchema#string